查看完整行情页>>

|

货币单位:美元(USD)

居里

Curis, Inc. (cris)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Kenneth I. Kaitin Kenneth I. Kaitin is on the board of Curis, Inc., Bio-Tree Systems, Inc., Centerphase Solutions, Inc. and QCDx LLC and Director-Drug Development Study at Tufts Center for the Study of Drug Development. In the past Dr. Kaitin occupied the position of President at Drug Information Association and Professor at Tufts University School of Medicine. Kenneth I. Kaitin received a doctorate and a graduate degree from the University of Rochester and an undergraduate degree from Cornell University.
Martyn D. Greenacre Martyn D. Greenacre is a businessperson who has been at the helm of 8 different companies and presently is Chairman for Life Mist Technologies, Inc. and Chairman at Curis, Inc. Mr. Greenacre is also on the board of Formula Pharmaceuticals, Inc. In his past career he was Chairman for Life Mist LLC, Chairman of Acusphere, Inc., Chief Executive Officer & Director at Delsys Pharmaceutical Corp., Chairman at Beijing Med-Pharm Corp., Chairman for BMP Sunstone Corp., President & Chief Executive Officer at Zynaxis, Inc., Senior Advisor at Arsenal Capital Management LP, Director & Chairman-European Operations at Smithkline Beecham Pharmaceuticals (India) Ltd. and Member-Executive Committee at Applera Corp. He received an MBA from Harvard Business School and an undergraduate degree from Harvard College.
James E. Dentzer Presently, James E. Dentzer holds the position of President, Chief Executive Officer & Director at Curis, Inc. In his past career he held the position of Chief Financial Officer of Amicus Therapeutics, Inc., Chief Financial Officer at Dicerna Pharmaceuticals, Inc., Controller for Biogen, Inc., Chief Financial Officer for Valeritas, Inc. and Chief Financial Officer-DuPont Flooring Systems at E.I. du Pont de Nemours & Co. He received an undergraduate degree from Boston College and an MBA from The University of Chicago Booth School of Business.
Marc Rubin Marc Rubin is a businessperson who has been at the head of 5 different companies and presently occupies the position of Executive Chairman for Titan Pharmaceuticals, Inc. Dr. Rubin is also on the board of 5 other companies. In the past he was President & Chief Executive Officer of Titan Pharmaceuticals, Inc., Senior Vice President-Global Clinical Pharmacology at GlaxoSmithKline Plc, Chairman for Schering Berlin, Inc., President at Berlex Pharmaceuticals, Inc., Head-Global Research & Development at Bayer Pharma AG and Head-Global Research & Development at Bayer Schering Pharma AG. Marc Rubin received a doctorate from Weill Cornell Medical College.
Lori Anne Kunkel Lori Anne Kunkel is on the board of Curis, Inc., Nurix Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Maverick Therapeutics, Inc. and Owner at Lak505, LLC. Dr. Kunkel previously occupied the position of Vice President-Clinical Development at Xencor, Inc., Chief Medical Officer at ACT Biotech, Inc., Chief Medical Officer of Syndax Pharmaceuticals, Inc., Vice President-Medical Affairs for Genitope Corp., Principal at XOMA Corp., Chief Medical Officer for Pharmacyclics LLC, Chief Medical Officer of Proteolix, Inc., Director at Tocagen, Inc., Director at Loxo Oncology, Inc., Principal at Salmedix, Inc., Principal at ZymoGenetics, Inc., Principal at Onyx Pharmaceuticals, Inc., Principal at DNAX Research Institute of Molecular & Cellular Biology, Inc, Head-Clinical Scientist at Genentech, Inc., Associate Director-Clinical Development at Chiron Corp. and Member-Bone Marrow Transplant Unit at the University of California. Dr. Kunkel received an undergraduate degree from the University of California San Diego and a doctorate from the University of Southern California.
Robert E. Martell Founder of Epi-Cure Pharmaceuticals, Inc., Robert E. Martell is Head-Research & Development at Curis, Inc. Dr. Martell is also Member of American Association for Cancer Research, Associate Chief-Division of Hematology/Oncology at Tufts Medical Center, Inc., Professor at Tufts University School of Medicine and Member of American Society of Clinical Oncology. In his past career Dr. Martell held the position of President & Director at Epi-Cure Pharmaceuticals, Inc., Director-Oncology Global Clinical Research at Bristol-Myers Squibb Co., Chief Medical Officer & Vice President at Mirati Therapeutics, Inc., Chief Medical Officer for Tesaro, Inc., Deputy Director-Medical Science Unit at Bayer Pharmaceuticals Corp., Associate Professor at Tufts Medical Center, Inc., Assistant Professor at Duke University Medical Center, Assistant Clinical Professor at Yale School of Medicine and Director-Neely Center at Clinical Cancer Research. Dr. Martell received an undergraduate degree from Kalamazoo College, a doctorate from the University of Michigan and a doctorate from Wayne State University (Michigan).
Rachel S. Blasbalg Rachel S. Blasbalg holds the position of Senior Director-Human Resources at Curis, Inc.
William E. Steinkrauss William E. Steinkrauss holds the position of Chief Financial Officer & Treasurer of Curis, Inc. Mr. Steinkrauss previously occupied the position of Director-Technical Accounting & Reporting at OvaScience, Inc. and Senior Manager-Technical Accounting at Cubist Pharmaceuticals LLC. He received a graduate degree and an undergraduate degree from Boston College.
Reinhard von Roemeling Reinhard von Roemeling occupies the position of Senior Vice President-Clinical Development at Curis, Inc. In the past he held the position of Global Head-Research & Development at HUYA Bioscience International LLC. He received a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Christine Guertin Presently, Christine Guertin is VP-Regulatory Affairs & Quality Assurance at Curis, Inc. Ms. Guertin previously occupied the position of Head-Regulatory Affairs at Synlogic, Inc. and Director-Regulatory Affairs at Array BioPharma, Inc. She received an undergraduate degree from Saint Joseph's College (Indiana) and a graduate degree from Regis College.
Nancy Soohoo Presently, Nancy Soohoo holds the position of General Counsel at Curis, Inc. In her past career she was Senior Counsel at NerveWire, Inc. and Manager-Information Technology Licensing at Harvard Pilgrim Health Care, Inc. Ms. Soohoo received an undergraduate degree from Boston College and a graduate degree from Northeastern University School of Law.